1. Home
  2. ICUCW vs RELX Comparison

ICUCW vs RELX Comparison

Compare ICUCW & RELX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUCW
  • RELX
  • Stock Information
  • Founded
  • ICUCW N/A
  • RELX 1903
  • Country
  • ICUCW United States
  • RELX United Kingdom
  • Employees
  • ICUCW 19
  • RELX N/A
  • Industry
  • ICUCW Biotechnology: Pharmaceutical Preparations
  • RELX Business Services
  • Sector
  • ICUCW Health Care
  • RELX Consumer Discretionary
  • Exchange
  • ICUCW Nasdaq
  • RELX Nasdaq
  • Market Cap
  • ICUCW N/A
  • RELX 97.3B
  • IPO Year
  • ICUCW 2021
  • RELX N/A
  • Fundamental
  • Price
  • ICUCW $0.02
  • RELX $53.32
  • Analyst Decision
  • ICUCW
  • RELX Strong Buy
  • Analyst Count
  • ICUCW 0
  • RELX 2
  • Target Price
  • ICUCW N/A
  • RELX N/A
  • AVG Volume (30 Days)
  • ICUCW N/A
  • RELX 878.0K
  • Earning Date
  • ICUCW N/A
  • RELX 07-24-2025
  • Dividend Yield
  • ICUCW N/A
  • RELX 1.11%
  • EPS Growth
  • ICUCW N/A
  • RELX 10.15
  • EPS
  • ICUCW N/A
  • RELX 1.29
  • Revenue
  • ICUCW N/A
  • RELX $11,810,658,884.00
  • Revenue This Year
  • ICUCW N/A
  • RELX $9.12
  • Revenue Next Year
  • ICUCW N/A
  • RELX $7.22
  • P/E Ratio
  • ICUCW N/A
  • RELX $40.80
  • Revenue Growth
  • ICUCW N/A
  • RELX 2.98
  • 52 Week Low
  • ICUCW N/A
  • RELX $43.45
  • 52 Week High
  • ICUCW N/A
  • RELX $56.33
  • Technical
  • Relative Strength Index (RSI)
  • ICUCW N/A
  • RELX 50.18
  • Support Level
  • ICUCW N/A
  • RELX $52.10
  • Resistance Level
  • ICUCW N/A
  • RELX $53.48
  • Average True Range (ATR)
  • ICUCW 0.00
  • RELX 0.47
  • MACD
  • ICUCW 0.00
  • RELX -0.03
  • Stochastic Oscillator
  • ICUCW 0.00
  • RELX 69.83

About ICUCW SeaStar Medical Holding Corporation Warrant

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

About RELX RELX PLC PLC

RELX is a global provider of information-based analytics and decision tools for professional and business customers in various industries. The company serves sectors such as science and medical research, risk management, and legal. In addition, RELX organizes large-scale digital and face-to-face events such as industry trade shows. Around 60% of revenue is generated in North America and about 20% in Europe.

Share on Social Networks: